iRadimed
IRMD
$44.70
Share price
1.94%
Change (1 day)
3.59%
Change (1 year)
Categories
P/S ratio for iRadimed (IRMD)
P/S ratio as of May 2024 (TTM): 8.46
According to iRadimed's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.45681. At the end of 2023 the company had a P/S ratio of 9.13.
P/S ratio history for iRadimed from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 9.13 | 36.85% |
| 2022 | 6.67 | -51.89% |
| 2021 | 13.9 | 56.68% |
| 2020 | 8.85 | 23.89% |
| 2019 | 7.14 | -19.12% |
| 2018 | 8.83 | 27.46% |
| 2017 | 6.93 | 89.35% |
| 2016 | 3.66 | -63.1% |
| 2015 | 9.91 | 11.24% |
| 2014 | 8.91 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Edwards Lifesciences EW | 8.54 | 0.94% | 🇺🇸 USA |
 NuVasive NUVA | 1.70 | -79.90% | 🇺🇸 USA |
 DexCom DXCM | 13.2 | 56.66% | 🇺🇸 USA |
 AtriCure ATRC | 2.69 | -68.16% | 🇺🇸 USA |